Back to FGEN Stock Lookup

FibroGen (FGEN) – Hot FDA News

Apr 6, 2021 04:04 PM FibroGen (FGEN) provided clarification of certain prior disclosures of U.S. primary cardiovascular safety analyses from roxadustat Phase 3 program for the treatment of anemia of CKD
Mar 1, 2021 04:06 PM FibroGen (FGEN) announces FDA will hold an advisory committee meeting to review the new drug application for roxadustat
Nov 8, 2019 02:09 PM
Nov 8, 2019 02:03 PM
May 9, 2019 04:45 PM
Oct 18, 2017 07:06 AM
Sep 13, 2017 07:04 AM
Jun 5, 2017 07:12 AM

Back to FGEN Stock Lookup